Home Newsfeeds Cowen & Co. Downgrades PhaseBio Pharmaceuticals to Market Perform

Cowen & Co. Downgrades PhaseBio Pharmaceuticals to Market Perform

Cowen & Co. analyst Phil Nadeau downgrades PhaseBio Pharmaceuticals (NASDAQ:PHAS) from Outperform to Market Perform.

byBenzinga Newsdesk

October 24, 2022

1 minute read

Cowen & Co. analyst Phil Nadeau downgrades PhaseBio Pharmaceuticals (NASDAQ:PHAS) from Outperform to Market Perform.

Needham Maintains Buy on Kornit Digital, Lowers Price Target to $33

By Benzinga Newsdesk

February 16, 7:23 AM

Needham analyst James Ricchiuti maintains Kornit Digital (NASDAQ:KRNT) with a Buy and lowers the price target from $35 to $33.

KRNT

PlayStation 5 Units Sell Briskly: 1.2M Per Month, 40,000+ Daily Average In 2023: Report

By Franca Quarneti

December 4, 5:39 PM

In the competitive landscape of gaming consoles, Sony Group Corp.'s (NYSE: SONY) PlayStation 5 (PS5) asserted its dominance as a beacon of technological advancement and cultural significance.

MSFT

Americold Partners With RSA Cold Chain And DP World To Bring A $35M New State-Of-The-Art Cold Chain Logistics Platform To Dubai

By Benzinga Newsdesk

December 12, 5:11 PM

Americold Realty Trust, Inc. (NYSE:COLD), through its joint venture RSA Cold Chain in Dubai, today announced plans to build and operate a new $35 million, state-of-the-art cold storage facility with 40,000 pallet

COLD